Genmab A/S (GE9)
FSX
Real-time Data
06:00 AM
Day's Range
202.8052 wk Range
170.60Overview - GE9 - Genmab A/S
Key Statistics
Valuation
Enterprise Value
17.68B
P/E (Trailing)
‪58.07‬
P/E (Forward)
‪36.31‬
PEG Ratio
‪36.31‬
Price / Book
‪3.26‬
EV / EBITDA
‪14.99‬
Profitability
Profit Margin
‪19.07%‬
Operating Margin
‪35.23%‬
Return on Assets
‪8.78%‬
Return on Equity
‪13.99%‬
Ownership
Shares Outstanding
61.49M
Float
58.96M
Held by Insiders
‪0.00%‬
Held by Institutions
‪40.02%‬
Price stats
Beta
‪0.68‬
50-Day Avg
‪248.94‬
200-Day Avg
‪247.66‬
Peers - GE9 - Genmab A/S
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- GE9FSXGenmab A/S12.55BMarket Cap+6.01%52-week change41.76P/E (Trailing)‪21.04%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - GE9 - Genmab A/S
About
Genmab A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of antibody-based therapeutics primarily for cancer and other serious diseases. Founded in 1998, it focuses on innovative human antibody technologies to create differentiated products that address…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
